TMPO and neoplasm: TP5 was also combined with herpes simplex virus and vaccinia virus.<h4>Results</h4>Here we show that combining adenovirus (ADV) with thymopentin (TP5) reprograms the tumor microenvironment and enhances antitumor efficacy in xenograft models.